Worth reading
42Recurring
Scored from 5 of 6 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
-13.9
% (year-on-year change in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
Third quarter1 October 2025 to 30 June 2026ConsolidatedJapanese GAAPNet Sales46,075¥ millionYear on year -2.6%Progress 70.9%
Operating profit6,895¥ millionYear on year -13.9%Progress 60.5%
Ordinary income7,290¥ millionYear on year -13.4%Progress 61.8%
Net income attributable to owners of the parent4,089¥ millionYear on year -0.8%Progress 49.9%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥119.72
Financial position at period-end
Total assets73,500¥ million
of which net assets 51,510 ¥ millionEquity ratio 69.4%vs. prior year-end -0.9pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueCosmetics Business ¥36,422 million (YoY -2.6%), Pharmaceuticals and food business ¥8,002 million (YoY -4.4%), Other Businesses ¥1,650 million (YoY +10.4%)
Segment profitCosmetics Business ¥8,084 million (YoY -9.9%), Pharmaceuticals and food business ¥562 million (YoY -24.6%), Other Businesses ¥155 million (YoY +13.5%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥65,000 million (YoY +0.4%)
Operating profit¥11,400 million (YoY +2.9%)
Ordinary income¥11,800 million (YoY +0.2%)
Net income¥8,200 million (YoY +2.1%)
Annual Dividend Forecast¥230.00 → ¥230.00（0.0%）
Factors Behind Changes in Business Performance
Although the economy showed signs of a gradual recovery, conditions remained uncertain due in part to the impact of the situation in the Middle East. As a medium- to long-term strategic theme, the Group pursued disciplined growth through sustainable management of each business.
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name None
Impairment loss¥120 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥924 million / Extraordinary loss Loss on disposal and sale of non-current assets ¥0 million, Impairment Losses ¥120 million, Loss on cancellation of insurance policies ¥164 million
Depreciation and amortization¥746 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End34,156,623 Shares
Treasury Shares at Period-End417 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025 to 30 June 2026 |
| Net Sales | ¥46,075 million (YoY -2.6%) |
| Operating profit | ¥6,895 million (YoY -13.9%) |
| Ordinary income | ¥7,290 million (YoY -13.4%) |
| Profit attributable to owners of the parent | ¥4,089 million (YoY -0.8%) |
| Net income per share | ¥119.72 |
| Equity ratio | End of the current fiscal period 69.4 / End of previous period 70.3 |
| Total assets | ¥73,500 million |
| Net assets | ¥51,510 million |
| Full-year earnings forecast | Net Sales ¥65,000 million (YoY +0.4%) / Operating profit ¥11,400 million (YoY +2.9%) / Ordinary income ¥11,800 million (YoY +0.2%) / Net income ¥8,200 million (YoY +2.1%) |
| Annual Dividend Forecast | ¥230.00 → ¥230.00（0.0%） |
| Segment revenue | Cosmetics Business ¥36,422 million (YoY -2.6%), Pharmaceuticals and food business ¥8,002 million (YoY -4.4%), Other Businesses ¥1,650 million (YoY +10.4%) |
| Segment profit | Cosmetics Business ¥8,084 million (YoY -9.9%), Pharmaceuticals and food business ¥562 million (YoY -24.6%), Other Businesses ¥155 million (YoY +13.5%) |
| Depreciation and amortization | ¥746 million |
| Impairment loss | ¥120 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥924 million / Extraordinary loss Loss on disposal and sale of non-current assets ¥0 million, Impairment Losses ¥120 million, Loss on cancellation of insurance policies ¥164 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 34,156,623 Shares |
| Treasury Shares at Period-End | 417 Shares |
| Factors Behind Changes in Business Performance | Although the economy showed signs of a gradual recovery, conditions remained uncertain due in part to the impact of the situation in the Middle East. As a medium- to long-term strategic theme, the Group pursued disciplined growth through sustainable management of each business. |
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company explained that although the economy showed signs of a gradual recovery, uncertainty continued due in part to the impact of the situation in the Middle East. It also stated that it is pursuing the medium- to long-term strategic theme of achieving disciplined growth through sustainable management of each business within the Group, but did not specify individual factors behind the decline in performance.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.